Maternal Asthma Is Associated with Reduced Female Fetal Growth

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 11, 2003, Pages 1317-1323

  Murphy, Vanessa E ^b   Gibson, Peter G ^b   Giles, Warwick B ^b   Zakar, Tamas ^b   Smith, Roger ^b   Bisits, Andrew M ^b   Kessell, Carolyn G ^b   Clifton, Vicki L ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b NONE

Author keywords

11 hydroxyste; Asthma; Fetal growth; Placenta; Pregnancy; Roid dehydrogenase type 2

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; ESTRIOL; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE;

ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FETUS; FETUS GROWTH; FETUS MONITORING; FOLLOW UP; HUMAN; IMMUNE SYSTEM; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PLACENTA FUNCTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SEX DIFFERENCE; UMBILICAL VEIN; VENOUS BLOOD;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; ASTHMA; ESTRIOL; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDROCORTISONE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; SEX FACTORS;

EID: 0344393434     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200303-374OC     Document Type: Article

References (58)

1. Varner AE. The increase in allergic respiratory diseases: survival of the fittest? Chest 2002;121:1308-1316.
2. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002;110:315-322.
3. Bahna SL, Bjerkedal T. The course and outcome of pregnancy in women with bronchial asthma. Acta Allergol 1972;27:397-406.
4. Schatz M, Patterson R, Zeitz S, O'Rourke J, Melam H. Corticosteroid therapy for the pregnant asthmatic patient. JAMA 1975;233:804-807.
5. Fitzsimons R, Greenberger PA, Patterson R. Outcome of pregnancy in women requiring corticosteroids for severe asthma. J Allergy Clin Immunol 1986;78:349-353.
6. Lao TT, Huengsburg M. Labour and delivery in mothers with asthma. Eur J Obstet Cynecol Reprod Biol 1990;35:183-190.
7. Clark SL. Asthma in pregnancy: National Asthma Education Program Working Group on Asthma and Pregnancy: National Institutes of Health, National Heart, Lung and Blood Institute. Obstet Cynecol 1993; 82:1036-1040.
8. Demissie K, Breckenridge MB, Rhoads GG. Infant and maternal outcomes in the pregnancies of asthmatic women. Am J Respir Crit Care Med 1998;158:1091-1095.
9. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-1016.
10. Moormann AM, Sullivan AD, Rochford RA, Chensue SW, Bock PJ, Nyirenda T, Meshnick SR. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 1999;180:1987-1993.
11. Skomsvoll JF, Ostensen M, Irgens LM, Baste V. Obstetrical and neonatal outcome in pregnant patients with rheumatic disease. Scand J Rheumatol Suppl 1998;107:109-112.
12. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989; 160:998-1001.
13. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93:2426-2430.
14. Aggarwal N, Sawhney H, Vasishta K, Chopra S, Bambery P. Pregnancy in patients with systemic lupus erythematosus. Aust N Z J Obstet Gynaecol 1999;39:28-30.
15. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564-567.
16. Barker DJ, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990;301:259-262.
17. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-580.
18. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-67.
19. Kuehr J, Karmaus W, Forster J, Frischer T, Hendel-Kramer A, Moseler M, Stephan V, Urbanek R, Weiss K. Sensitization to four common inhalant allergens within 302 nuclear families. Clin Exp Allergy 1993; 23:600-605.
20. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-4737.
21. Clifton VL, Giles WB, Smith R, Bisits A, Hempenstall P, Kessell CG, Gibson PG. Alterations of placental vascular function in asthmatic pregnancies. Am J Respir Crit Care Med 2001;164:1-8.
22. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J Immunol 1998;160:2523-2530.
23. Hahn-Zoric M, Hagberg H, Kjellmer I, Ellis J, Wennergren M, Hanson LA. Aberrations in placental cytokine mRNA related to intrauterine growth retardation. Pediatr Res 2002;51:201-206.
24. Ida A, Tsuji Y, Muranaka J, Kanazawa R, Nakata Y, Adachi S, Okamura H, Koyama K. IL-18 in pregnancy: the elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies. J Reprod Immunol 2000;47:65-74.
25. Hayashi M, Ohkura T. Elevated levels of serum macrophage colony-stimulating factor in normotensive pregnancies complicated by intrauterine fetal growth restriction. Exp Hematol 2002;30:388-393.
26. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998;13:799-804.
27. Murphy VE, Gibson PG, Giles WB, Zakar T, Smith R, Kessell CG, Clifton VL. Inflammatory factors have sex-specific effects on fetal growth in humans [abstract]. Ceska Gynekologie 2002;67(3 Suppl):16.
28. Murphy VE, Gibson PG, Giles WB, Smith R, Clifton VL. A novel model for examining fetal growth restriction in human pregnancy [abstract]. J Soc Gynecol Investig 2003;10(2 Suppl):268A.
29. National Asthma Campaign. Asthma Management Handbook. Sydney. Australia: National Asthma Council Australia; 1996.
30. National Institutes of Health. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute; 1997.
31. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma: International Study Group. Eur Respir J 1993;6:877-885.
32. Kitchen WH, Robinson HP, Dickinson AJ. Revised intrauterine growth curves for an Australian hospital population. Aust Paediatr J 1983; 19:157-161.
33. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL. Reduced 11 beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002;87:1660-1668.
34. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998; 17:1261-1291.
35. Senn S, Stevens L, Chaturvedi N. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Stat Med 2000; 19:861-877.
36. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatal 2000;5:231-241.
37. Dodds L, Armson BA, Alexander S. Use of asthma drugs is less among women pregnant with boys rather than girls. BMJ 1999;318:1011.
38. Beecroft N, Cochrane GM, Milburn HJ. Effect of sex of fetus on asthma during pregnancy: blind prospective study. BMJ 1998;317:856-857.
39. Liu S, Wen SW, Demissie K, Marcoux S, Kramer MS. Maternal asthma and pregnancy outcomes: a retrospective cohort study. Am J Obstet Gynecol 2001;184:90-96.
40. Mazzarella G, Grella E, D'Auria D, Paciocco G, Perna F, Petillo O, Peluso G. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-alpha in asthmatic patients. Allergy 2000;55:36-41.
41. Tang C, Rolland JM, Li X, Ward C, Bish R, Walters EH. Alveolar macrophages from atopic asthmatics, but not atopic nonasthmatics, enhance interleukin-5 production by CD4+ T cells. Am J Respir Crit Care Med 1998;157:1120-1126.
42. Tang C, Rolland JM, Ward C, Thien F, Li X, Gollant S, Walters EH. Differential regulation of allergen-specific T(H2)-but not T(H1)-type responses by alveolar macrophages in atopic asthma. J Allergy Clin Immunol 1998;102:368-375.
43. Zhu YK, Liu X, Wang H, Kohyama T, Wen FQ, Skold CM, Rennard SI. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. J Allergy Clin Immunol 2001;108: 989-996.
44. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-696.
45. Lim S, John M, Seybold J, Taylor D, Witt C Barnes PJ, Chung KF. Increased interleukin-10 and macrophage inflammatory protein-1 alpha release from blood monocytes ex vivo during late-phase response to allergen in asthma. Allergy 2000;55:489-495.
46. Mathy NL, Scheuer W, Lanzendorfer M, Honold K, Ambrosius D, Norley S, Kurth R. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 2000;100:63-69.
47. Louis R, Bury T, Corhay JL, Radermecker MF. Acute bronchial and hematologic effects following inhalation of a single dose of PAF: comparison between asthmatics and normal subjects. Chest 1994;106: 1094-1099.
48. Schatz M, Zeiger RS. Hoffman CP. Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women: Kaiser-Permanente Asthma and Pregnancy Study Group. Chest 1990;98:389-392.
49. Fowden AL, Szemere J, Hughes P, Gilmour RS, Forhead AJ. The effects of cortisol on the growth rate of the sheep fetus during late gestation. J Endocrinol 1996;151:97-105.
50. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.
51. United States Department of Health and Human Services. The health benefits of smoking cessation: a report of the Surgeon General. Rockville, MD: Centers for Disease Control; 1990.
52. Dean F, Matthews SG. Maternal dexamethasone treatment in late gestation alters glucocorticoid and mineralocorticoid receptor mRNA in the fetal guinea pig brain. Brain Res 1999;846:253-259.
53. Welberg LA, Seckl JR. Holmes MC. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foeto-placental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur J Neurosci 2000;12:1047-1054.
54. Smith JT, Waddell BJ. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 2000;141:2422-2428.
55. Siiteri PK, MacDonald PC. Placental estrogen biosynthesis during human pregnancy. J Clin Endocrinol Metab 1966;26:751-761.
56. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981;141:276-287.
57. Papageorgiou AN; Colle E, Farri-Kostopoulos E; Gelfand MM. Incidence of respiratory distress syndrome following antenatal betamethasone: role of sex, type of delivery, and prolonged rupture of membranes. Pediatrics 1981;67:614-617.
58. Chao TC, Van Alten PJ, Greager JA, Walter RJ. Steroid sex hormones regulate the release of tumour necrosis factor by macrophages. Cell Immunol 1995;160:43-49.